Cipher Pharmaceuticals (OTCMKTS:CPHRF) Stock Price Crosses Above 50 Day Moving Average – Should You Sell?

Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRFGet Free Report) (TSE:CPH)’s share price passed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $11.18 and traded as high as $13.28. Cipher Pharmaceuticals shares last traded at $13.00, with a volume of 8,501 shares traded.

Cipher Pharmaceuticals Trading Up 6.7%

The business has a fifty day moving average price of $11.18 and a two-hundred day moving average price of $10.85.

About Cipher Pharmaceuticals

(Get Free Report)

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company that develops, acquires and commercializes prescription products in respiratory and dermatology markets. Founded in 2004 and headquartered in Vancouver, British Columbia, the company focuses on in-licensing established therapies and launching them under its own commercial infrastructure in North America.

In the respiratory segment, Cipher markets generic inhalation therapies for conditions such as asthma and chronic obstructive pulmonary disease (COPD).

Featured Stories

Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.